Results 221 to 230 of about 101,301 (311)

Lateral ventricular choroid plexus enlargement in patients with spontaneous intracranial hypotension

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study aimed to evaluate the choroid plexus volume in patients with spontaneous intracranial hypotension (SIH), including the lateral, third, and fourth ventricles, and explore its potential relationship with clinical characteristics. Background SIH is caused by cerebrospinal fluid (CSF) leaks. The choroid plexus is predominantly
Sojung Yoon   +6 more
wiley   +1 more source

Headache in individuals undergoing hormone therapy for gender transition: A cross‐sectional, observational study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the prevalence, frequency, and characteristics of headache disorders in transgender individuals receiving gender‐affirming hormone therapy (GAHT), and to explore the relationship between GAHT and headache pathophysiology.
Lucia Jimena Zavala   +4 more
wiley   +1 more source

Telemedicine is effective and safe for clinical management of patients with headache disorders: An American Headache Society position statement

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This study was undertaken to review the published literature and provide a position statement from the American Headache Society regarding the safety, efficacy, and impact on access to care of telemedicine for the clinical management of patients with headache disorders.
Karissa N. Arca   +6 more
wiley   +1 more source

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective/Background This study was undertaken to assess participants' impression of use and satisfaction with STS101 in a long‐term, open‐label safety study. The ASCEND study assessed the safety and tolerability of STS101, an investigational drug–device combination of 5.2 mg dihydroergotamine in a single‐use nasal delivery device for the ...
Jessica Ailani   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy